Hormonal

Insulin

Also known as: Regular Insulin, Humulin, Novolin

FDA Approved
Share:

Key Facts: Insulin

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - Essential diabetes medication; Awiqli (once-weekly basal insulin) approved March 26, 2026 for T2D
Administration
Subcutaneous injection, pump, or inhaled
Typical Dose
Limited community data available
Frequency
See research protocols
Duration
Lifelong for Type 1 diabetes
Also Known As
Regular Insulin, Humulin, Novolin

Mechanism of Action

Insulin binds to insulin receptors, triggering glucose uptake into cells, glycogen synthesis, protein synthesis, and fat storage. It's the primary anabolic hormone regulating blood glucose levels.

Research Summary

Discovery revolutionized diabetes treatment in 1921. Continuous innovation from animal-derived to recombinant human to analog insulins. Remains essential for Type 1 and many Type 2 diabetes patients. On March 26, 2026, the FDA approved Awiqli (insulin icodec-abae), the first and only once-weekly basal insulin for adults with type 2 diabetes, based on the ONWARDS Phase 3 trial program. Not approved for Type 1 due to hypoglycemia concerns.

Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosing

Community experience

Common Dose

Limited community data available

Range

See research dosing

Frequency

See research protocols

Research Dosing

Scientific studies

Highly individualized dosing

Doses from Studies

Varies widely by patient needs

FDA Approved Labeling - Prescribed dose

Basal + bolus regimens common

FDA Approved Labeling - Prescribed dose

Duration

Lifelong for Type 1 diabetes

Administration

Subcutaneous injection, pump, or inhaled

Timing & Administration

Best Time to Take

Morning

Follow specific protocol

Food Recommendation

Take on empty stomach

Why This Timing?

Metabolic peptides often work best when taken in the morning to support daytime energy expenditure.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Hypoglycemia (most common and serious)
  • Weight gain
  • Injection site reactions
  • Lipodystrophy
  • Allergic reactions
  • Hypokalemia
  • Vision changes
  • Low therapeutic index - requires careful monitoring
  • FDA approved

References

Research This Peptide Further

Frequently Asked Questions

What does Insulin do?

The essential peptide hormone for glucose metabolism. Multiple formulations from rapid to long-acting available for diabetes management.

How does Insulin work?

Insulin binds to insulin receptors, triggering glucose uptake into cells, glycogen synthesis, protein synthesis, and fat storage. It's the primary anabolic hormone regulating blood glucose levels.

Is Insulin FDA approved?

Yes, Insulin is FDA approved. FDA Approved - Essential diabetes medication; Awiqli (once-weekly basal insulin) approved March 26, 2026 for T2D

What are the side effects of Insulin?

Reported side effects include: Hypoglycemia (most common and serious), Weight gain, Injection site reactions, Lipodystrophy, Allergic reactions. Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of Insulin?

Community-reported common dose: Limited community data available (See research protocols). Range: See research dosing. Administration: Subcutaneous injection, pump, or inhaled. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with Insulin or used in similar applications.

Want updates on Insulin research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.